Cancer is complex — there is no routine cancer, and while molecular and genetic testing are offered for all cancers treated at the OSUCCC – James, it is not the standard for most cancer treatment centers or even the most advanced private practices. Rather, precision medicine is usually only offered at leading academic medical centers such as the OSUCCC – James.
In the future, however, the OSUCCC – James cancer experts hope to see this kind of advanced detection, diagnosis and treatment offered across the nation.
“That should be our goal,” says Sameek Roychowdhury, MD, PhD, genomics expert and medical oncologist. “We want everyone to view the arrival of precision medicine as something as life-changing as the invention of the microscope was—a new way to view, understand, and beat cancer. This is big. It is dramatically changing the way we look at cancer.”
Currently, less than 10 percent of medical labs across the country have implemented precision medicine technology. “Patients should have access to the kind of novel testing and treatments we have here,” Roychowdhury says. “The goal of precision testing and therapy is to improve the care of patients with cancer.”
The OSUCCC – James cancer specialists and subspecialists are nationally and internationally renowned in research and advanced patient care. In fact, our physician experts actually help write the national clinical guidelines for treating specific cancers. Because of that expertise and understanding of cancer’s complexities and how it acts and reacts differently in each person, the very best outcomes — and the most effective means of treating cancer patients — come from a team approach.
At the OSUCCC – James, the cancer treatment teams include internationally recognized medical oncologists, surgical oncologists, radiation oncologists, geneticists, nutritionists and more. Also on those team are cancer researchers who help sequence tumors to identify key molecules that fuel each patient’s cancer and who then develop drugs that target only those particular molecules. Working together and across medical disciplines, this super sub-specialized team develops individualized, highly targeted treatment plans that specifically target the molecular and biological makeup of a patient’s individual cancer.
One of only four centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs, the OSUCCC – James offers patients access to more clinical trials than nearly any other cancer hospital in the region and more of the most targeted, most effective treatment options, many of which are available only at the OSUCCC – James.
If you’ve been diagnosed with cancer, would like a second opinion or would like to speak with a cancer specialist, please call The James Line at 800-293-5066 or 614-293-5066 to make an appointment.